Reports

Industry Research Reports

Global Custom Peptide CDMO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Custom Peptide CDMO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-09-06

Pages: 108 Pages

Report ld: 4952428

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Custom Peptide CDMO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.

The North America Custom Peptide CDMO Services market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of Custom Peptide CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Custom Peptide CDMO Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

  • Bachem
  • CordenPharma
  • PolyPeptide
  • AmbioPharm
  • Genscript
  • Thermo Fisher
  • USV Peptides
  • Bio Basic
  • ScinoPharm
  • JPT
  • CBL
  • Piramal Pharma
  • CPC Scientific
  • Creative Peptides
  • Chinese Peptide Company
  • ChengDu ShengNuo Biotec
  • AppTec Co., Ltd.
  • GL Biochem

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • GMP Services
  • Non-GMP Services

Segment by Application

  • Commercial
  • Scientific Research
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Custom Peptide CDMO Services market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-GMP Services in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research in India).

marn_i1

Chapter 6: Regional revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Custom Peptide CDMO Services value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 GMP Services

1.2.3 Non-GMP Services

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Commercial

1.3.3 Scientific Research

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Custom Peptide CDMO Services Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Custom Peptide CDMO Services Revenue Market Share by Region (2020-2025)

2.4 Global Custom Peptide CDMO Services Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Custom Peptide CDMO Services Market Size and Prospective (2020-2031)

2.5.2 Europe Custom Peptide CDMO Services Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific Custom Peptide CDMO Services Market Size and Prospective (2020-2031)

2.5.4 Latin America Custom Peptide CDMO Services Market Size and Prospective (2020-2031)

2.5.5 Middle East & Africa Custom Peptide CDMO Services Market Size and Prospective (2020-2031)

muLu

3 Breakdown Data by Type

3.1 Global Custom Peptide CDMO Services Historic Market Size by Type (2020-2025)

3.2 Global Custom Peptide CDMO Services Forecasted Market Size by Type (2026-2031)

3.3 Different Types Custom Peptide CDMO Services Representative Players

muLu

4 Breakdown Data by Application

4.1 Global Custom Peptide CDMO Services Historic Market Size by Application (2020-2025)

4.2 Global Custom Peptide CDMO Services Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Custom Peptide CDMO Services Application

muLu

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Custom Peptide CDMO Services Players by Revenue (2020-2025)

5.1.2 Global Custom Peptide CDMO Services Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Custom Peptide CDMO Services Revenue

5.4 Global Custom Peptide CDMO Services Market Concentration Analysis

5.4.1 Global Custom Peptide CDMO Services Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Custom Peptide CDMO Services Revenue in 2024

5.5 Global Key Players of Custom Peptide CDMO Services Head office and Area Served

5.6 Global Key Players of Custom Peptide CDMO Services, Product and Application

5.7 Global Key Players of Custom Peptide CDMO Services, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Custom Peptide CDMO Services Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Custom Peptide CDMO Services Market Size by Type (2020-2025)

6.1.2.2 North America Custom Peptide CDMO Services Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Custom Peptide CDMO Services Market Size by Application (2020-2025)

6.1.3.2 North America Custom Peptide CDMO Services Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Custom Peptide CDMO Services Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Custom Peptide CDMO Services Market Size by Type (2020-2025)

6.2.2.2 Europe Custom Peptide CDMO Services Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Custom Peptide CDMO Services Market Size by Application (2020-2025)

6.2.3.2 Europe Custom Peptide CDMO Services Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific Custom Peptide CDMO Services Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Custom Peptide CDMO Services Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific Custom Peptide CDMO Services Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Custom Peptide CDMO Services Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific Custom Peptide CDMO Services Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

6.4 Latin America Market: Players, Segments and Downstream

6.4.1 Latin America Custom Peptide CDMO Services Revenue by Company (2020-2025)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Custom Peptide CDMO Services Market Size by Type (2020-2025)

6.4.2.2 Latin America Custom Peptide CDMO Services Market Share by Type (2020-2025)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Custom Peptide CDMO Services Market Size by Application (2020-2025)

6.4.3.2 Latin America Custom Peptide CDMO Services Market Share by Application (2020-2025)

6.4.4 Latin America Market Trend and Opportunities

6.5 Middle East & Africa Market: Players, Segments and Downstream

6.5.1 Middle East & Africa Custom Peptide CDMO Services Revenue by Company (2020-2025)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Custom Peptide CDMO Services Market Size by Type (2020-2025)

6.5.2.2 Middle East & Africa Custom Peptide CDMO Services Market Share by Type (2020-2025)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Custom Peptide CDMO Services Market Size by Application (2020-2025)

6.5.3.2 Middle East & Africa Custom Peptide CDMO Services Market Share by Application (2020-2025)

6.5.4 Middle East & Africa Market Trend and Opportunities

muLu

7 Key Players Profiles

7.1 Bachem

7.1.1 Bachem Company Details

7.1.2 Bachem Business Overview

7.1.3 Bachem Custom Peptide CDMO Services Introduction

7.1.4 Bachem Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.1.5 Bachem Recent Development

7.2 CordenPharma

7.2.1 CordenPharma Company Details

7.2.2 CordenPharma Business Overview

7.2.3 CordenPharma Custom Peptide CDMO Services Introduction

7.2.4 CordenPharma Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.2.5 CordenPharma Recent Development

7.3 PolyPeptide

7.3.1 PolyPeptide Company Details

7.3.2 PolyPeptide Business Overview

7.3.3 PolyPeptide Custom Peptide CDMO Services Introduction

7.3.4 PolyPeptide Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.3.5 PolyPeptide Recent Development

7.4 AmbioPharm

7.4.1 AmbioPharm Company Details

7.4.2 AmbioPharm Business Overview

7.4.3 AmbioPharm Custom Peptide CDMO Services Introduction

7.4.4 AmbioPharm Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.4.5 AmbioPharm Recent Development

7.5 Genscript

7.5.1 Genscript Company Details

7.5.2 Genscript Business Overview

7.5.3 Genscript Custom Peptide CDMO Services Introduction

7.5.4 Genscript Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.5.5 Genscript Recent Development

7.6 Thermo Fisher

7.6.1 Thermo Fisher Company Details

7.6.2 Thermo Fisher Business Overview

7.6.3 Thermo Fisher Custom Peptide CDMO Services Introduction

7.6.4 Thermo Fisher Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.6.5 Thermo Fisher Recent Development

7.7 USV Peptides

7.7.1 USV Peptides Company Details

7.7.2 USV Peptides Business Overview

7.7.3 USV Peptides Custom Peptide CDMO Services Introduction

7.7.4 USV Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.7.5 USV Peptides Recent Development

7.8 Bio Basic

7.8.1 Bio Basic Company Details

7.8.2 Bio Basic Business Overview

7.8.3 Bio Basic Custom Peptide CDMO Services Introduction

7.8.4 Bio Basic Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.8.5 Bio Basic Recent Development

7.9 ScinoPharm

7.9.1 ScinoPharm Company Details

7.9.2 ScinoPharm Business Overview

7.9.3 ScinoPharm Custom Peptide CDMO Services Introduction

7.9.4 ScinoPharm Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.9.5 ScinoPharm Recent Development

7.10 JPT

7.10.1 JPT Company Details

7.10.2 JPT Business Overview

7.10.3 JPT Custom Peptide CDMO Services Introduction

7.10.4 JPT Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.10.5 JPT Recent Development

7.11 CBL

7.11.1 CBL Company Details

7.11.2 CBL Business Overview

7.11.3 CBL Custom Peptide CDMO Services Introduction

7.11.4 CBL Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.11.5 CBL Recent Development

7.12 Piramal Pharma

7.12.1 Piramal Pharma Company Details

7.12.2 Piramal Pharma Business Overview

7.12.3 Piramal Pharma Custom Peptide CDMO Services Introduction

7.12.4 Piramal Pharma Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.12.5 Piramal Pharma Recent Development

7.13 CPC Scientific

7.13.1 CPC Scientific Company Details

7.13.2 CPC Scientific Business Overview

7.13.3 CPC Scientific Custom Peptide CDMO Services Introduction

7.13.4 CPC Scientific Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.13.5 CPC Scientific Recent Development

7.14 Creative Peptides

7.14.1 Creative Peptides Company Details

7.14.2 Creative Peptides Business Overview

7.14.3 Creative Peptides Custom Peptide CDMO Services Introduction

7.14.4 Creative Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.14.5 Creative Peptides Recent Development

7.15 Chinese Peptide Company

7.15.1 Chinese Peptide Company Company Details

7.15.2 Chinese Peptide Company Business Overview

7.15.3 Chinese Peptide Company Custom Peptide CDMO Services Introduction

7.15.4 Chinese Peptide Company Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.15.5 Chinese Peptide Company Recent Development

7.16 ChengDu ShengNuo Biotec

7.16.1 ChengDu ShengNuo Biotec Company Details

7.16.2 ChengDu ShengNuo Biotec Business Overview

7.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Introduction

7.16.4 ChengDu ShengNuo Biotec Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.16.5 ChengDu ShengNuo Biotec Recent Development

7.17 AppTec Co., Ltd.

7.17.1 AppTec Co., Ltd. Company Details

7.17.2 AppTec Co., Ltd. Business Overview

7.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Introduction

7.17.4 AppTec Co., Ltd. Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.17.5 AppTec Co., Ltd. Recent Development

7.18 GL Biochem

7.18.1 GL Biochem Company Details

7.18.2 GL Biochem Business Overview

7.18.3 GL Biochem Custom Peptide CDMO Services Introduction

7.18.4 GL Biochem Revenue in Custom Peptide CDMO Services Business (2020-2025)

7.18.5 GL Biochem Recent Development

muLu

8 Custom Peptide CDMO Services Market Dynamics

8.1 Custom Peptide CDMO Services Industry Trends

8.2 Custom Peptide CDMO Services Market Drivers

8.3 Custom Peptide CDMO Services Market Challenges

8.4 Custom Peptide CDMO Services Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Custom Peptide CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Custom Peptide CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Custom Peptide CDMO Services Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Custom Peptide CDMO Services Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Custom Peptide CDMO Services Revenue Share by Region (2020-2025)
Table 6. Global Custom Peptide CDMO Services Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Custom Peptide CDMO Services Revenue Share Forecast by Region (2026-2031)
Table 8. Global Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Custom Peptide CDMO Services Revenue Market Share by Type (2020-2025)
Table 10. Global Custom Peptide CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Custom Peptide CDMO Services Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Custom Peptide CDMO Services Revenue Market Share by Application (2020-2025)
Table 15. Global Custom Peptide CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Custom Peptide CDMO Services Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Custom Peptide CDMO Services Application
Table 18. Global Custom Peptide CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Custom Peptide CDMO Services Market Share by Players (2020-2025)
Table 20. Global Top Custom Peptide CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Peptide CDMO Services as of 2024)
Table 21. Ranking of Global Top Custom Peptide CDMO Services Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Custom Peptide CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Custom Peptide CDMO Services, Headquarters and Area Served
Table 24. Global Key Players of Custom Peptide CDMO Services, Product and Application
Table 25. Global Key Players of Custom Peptide CDMO Services, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Custom Peptide CDMO Services Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Custom Peptide CDMO Services Revenue Market Share by Company (2020-2025)
Table 29. North America Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Custom Peptide CDMO Services Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Custom Peptide CDMO Services Revenue Market Share by Company (2020-2025)
Table 33. Europe Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Custom Peptide CDMO Services Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Custom Peptide CDMO Services Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Custom Peptide CDMO Services Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Custom Peptide CDMO Services Revenue Market Share by Company (2020-2025)
Table 41. Latin America Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Custom Peptide CDMO Services Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Custom Peptide CDMO Services Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Custom Peptide CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Custom Peptide CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 47. Bachem Company Details
Table 48. Bachem Business Overview
Table 49. Bachem Custom Peptide CDMO Services Product
Table 50. Bachem Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 51. Bachem Recent Development
Table 52. CordenPharma Company Details
Table 53. CordenPharma Business Overview
Table 54. CordenPharma Custom Peptide CDMO Services Product
Table 55. CordenPharma Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 56. CordenPharma Recent Development
Table 57. PolyPeptide Company Details
Table 58. PolyPeptide Business Overview
Table 59. PolyPeptide Custom Peptide CDMO Services Product
Table 60. PolyPeptide Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 61. PolyPeptide Recent Development
Table 62. AmbioPharm Company Details
Table 63. AmbioPharm Business Overview
Table 64. AmbioPharm Custom Peptide CDMO Services Product
Table 65. AmbioPharm Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 66. AmbioPharm Recent Development
Table 67. Genscript Company Details
Table 68. Genscript Business Overview
Table 69. Genscript Custom Peptide CDMO Services Product
Table 70. Genscript Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 71. Genscript Recent Development
Table 72. Thermo Fisher Company Details
Table 73. Thermo Fisher Business Overview
Table 74. Thermo Fisher Custom Peptide CDMO Services Product
Table 75. Thermo Fisher Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 76. Thermo Fisher Recent Development
Table 77. USV Peptides Company Details
Table 78. USV Peptides Business Overview
Table 79. USV Peptides Custom Peptide CDMO Services Product
Table 80. USV Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 81. USV Peptides Recent Development
Table 82. Bio Basic Company Details
Table 83. Bio Basic Business Overview
Table 84. Bio Basic Custom Peptide CDMO Services Product
Table 85. Bio Basic Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 86. Bio Basic Recent Development
Table 87. ScinoPharm Company Details
Table 88. ScinoPharm Business Overview
Table 89. ScinoPharm Custom Peptide CDMO Services Product
Table 90. ScinoPharm Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 91. ScinoPharm Recent Development
Table 92. JPT Company Details
Table 93. JPT Business Overview
Table 94. JPT Custom Peptide CDMO Services Product
Table 95. JPT Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 96. JPT Recent Development
Table 97. CBL Company Details
Table 98. CBL Business Overview
Table 99. CBL Custom Peptide CDMO Services Product
Table 100. CBL Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 101. CBL Recent Development
Table 102. Piramal Pharma Company Details
Table 103. Piramal Pharma Business Overview
Table 104. Piramal Pharma Custom Peptide CDMO Services Product
Table 105. Piramal Pharma Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 106. Piramal Pharma Recent Development
Table 107. CPC Scientific Company Details
Table 108. CPC Scientific Business Overview
Table 109. CPC Scientific Custom Peptide CDMO Services Product
Table 110. CPC Scientific Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 111. CPC Scientific Recent Development
Table 112. Creative Peptides Company Details
Table 113. Creative Peptides Business Overview
Table 114. Creative Peptides Custom Peptide CDMO Services Product
Table 115. Creative Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 116. Creative Peptides Recent Development
Table 117. Chinese Peptide Company Company Details
Table 118. Chinese Peptide Company Business Overview
Table 119. Chinese Peptide Company Custom Peptide CDMO Services Product
Table 120. Chinese Peptide Company Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 121. Chinese Peptide Company Recent Development
Table 122. ChengDu ShengNuo Biotec Company Details
Table 123. ChengDu ShengNuo Biotec Business Overview
Table 124. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product
Table 125. ChengDu ShengNuo Biotec Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 126. ChengDu ShengNuo Biotec Recent Development
Table 127. AppTec Co., Ltd. Company Details
Table 128. AppTec Co., Ltd. Business Overview
Table 129. AppTec Co., Ltd. Custom Peptide CDMO Services Product
Table 130. AppTec Co., Ltd. Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 131. AppTec Co., Ltd. Recent Development
Table 132. GL Biochem Company Details
Table 133. GL Biochem Business Overview
Table 134. GL Biochem Custom Peptide CDMO Services Product
Table 135. GL Biochem Revenue in Custom Peptide CDMO Services Business (2020-2025) & (US$ Million)
Table 136. GL Biochem Recent Development
Table 137. Custom Peptide CDMO Services Market Trends
Table 138. Custom Peptide CDMO Services Market Drivers
Table 139. Custom Peptide CDMO Services Market Challenges
Table 140. Custom Peptide CDMO Services Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Custom Peptide CDMO Services Product Picture
Figure 2. Global Custom Peptide CDMO Services Market Share by Type: 2024 VS 2031
Figure 3. GMP Services Features
Figure 4. Non-GMP Services Features
Figure 5. Global Custom Peptide CDMO Services Market Share by Application: 2024 VS 2031
Figure 6. Commercial
Figure 7. Scientific Research
Figure 8. Other
Figure 9. Custom Peptide CDMO Services Report Years Considered
Figure 10. Global Custom Peptide CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Custom Peptide CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Custom Peptide CDMO Services Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Custom Peptide CDMO Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Custom Peptide CDMO Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Asia-Pacific Custom Peptide CDMO Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Latin America Custom Peptide CDMO Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Middle East & Africa Custom Peptide CDMO Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Custom Peptide CDMO Services Market Share by Players in 2024
Figure 19. Global Top Custom Peptide CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Peptide CDMO Services as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Custom Peptide CDMO Services Revenue in 2024
Figure 21. North America Custom Peptide CDMO Services Market Share by Type (2020-2025)
Figure 22. North America Custom Peptide CDMO Services Market Share by Application (2020-2025)
Figure 23. Europe Custom Peptide CDMO Services Market Share by Type (2020-2025)
Figure 24. Europe Custom Peptide CDMO Services Market Share by Application (2020-2025)
Figure 25. Asia-Pacific Custom Peptide CDMO Services Market Share by Type (2020-2025)
Figure 26. Asia-Pacific Custom Peptide CDMO Services Market Share by Application (2020-2025)
Figure 27. Latin America Custom Peptide CDMO Services Market Share by Type (2020-2025)
Figure 28. Latin America Custom Peptide CDMO Services Market Share by Application (2020-2025)
Figure 29. Middle East & Africa Custom Peptide CDMO Services Market Share by Type (2020-2025)
Figure 30. Middle East & Africa Custom Peptide CDMO Services Market Share by Application (2020-2025)
Figure 31. Bachem Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 32. CordenPharma Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 33. PolyPeptide Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 34. AmbioPharm Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 35. Genscript Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 36. Thermo Fisher Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 37. USV Peptides Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 38. Bio Basic Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 39. ScinoPharm Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 40. JPT Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 41. CBL Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 42. Piramal Pharma Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 43. CPC Scientific Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 44. Creative Peptides Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 45. Chinese Peptide Company Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 46. ChengDu ShengNuo Biotec Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 47. AppTec Co., Ltd. Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 48. GL Biochem Revenue Growth Rate in Custom Peptide CDMO Services Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Custom Peptide CDMO Services market?zhanKai
The top companies in the global Custom Peptide CDMO Services market are Bachem、CordenPharma、PolyPeptide.
den_biaoTiZhungShi

Related Reports

Global Custom Peptide CDMO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-09-06

Pages: 108 Pages

Report ld: 4952428

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now